246 related articles for article (PubMed ID: 36576548)
1. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.
Gou X; Jia W; He C; Yuan X; Niu J; Xu J; Han N; Zhu Y; Wang W; Tie J
Eur Radiol; 2023 May; 33(5):3407-3415. PubMed ID: 36576548
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
Campos S; Gomes D; Sofia C
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
[TBL] [Abstract][Full Text] [Related]
6. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis.
Jindal A; Mukund A; Kumar G; Sarin SK
Liver Int; 2019 Nov; 39(11):2164-2173. PubMed ID: 31356712
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.
Andrade RJ; Martin-Palanca A; Fraile JM; Alcantara R; Carmona C; Medina MC; Muñoz V; Melgarejo F
J Clin Gastroenterol; 1996 Jun; 22(4):305-7. PubMed ID: 8771428
[TBL] [Abstract][Full Text] [Related]
9. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
12. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
[TBL] [Abstract][Full Text] [Related]
13. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
14. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
[TBL] [Abstract][Full Text] [Related]
15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites.
Young S; Bermudez J; Zhang L; Rostambeigi N; Golzarian J
Diagn Interv Imaging; 2019 May; 100(5):303-308. PubMed ID: 30522911
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.
Qin JP; Jiang MD; Tang W; Wu XL; Yao X; Zeng WZ; Xu H; He QW; Gu M
World J Gastroenterol; 2013 Nov; 19(44):8085-92. PubMed ID: 24307804
[TBL] [Abstract][Full Text] [Related]
18. Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax.
Romero S; Lim AK; Singh G; Kodikara C; Shingaki-Wells R; Chen L; Hui S; Robertson M
World J Gastroenterol; 2022 Sep; 28(35):5175-5187. PubMed ID: 36188717
[TBL] [Abstract][Full Text] [Related]
19. Refractory Hepatic Hydrothorax in the Absence of Ascites as a First Sign of Cirrhosis.
Aloreidi K; Gedela M; Wabwire G; Mothapothula UM; Jha L
S D Med; 2018 Apr; 71(4):168-170. PubMed ID: 29996034
[TBL] [Abstract][Full Text] [Related]
20. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
